Clinical trial
A Single Patient Study (SPS) of Sapropterin for Multisystem Smooth Muscle Dysfunction Syndrome (MSMDS).
NCT07574034 is registered in ClinicalTrials.gov with Gregor Andelfinger as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Single Patient Study (SPS) of Sapropterin for Multisystem Smooth Muscle Dysfunction Syndrome (MSMDS).
- Lead sponsor
- Gregor Andelfinger
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- June 1, 2026
- Completion date
- June 1, 2030
- Enrollment
- 1 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
multisystemic smooth muscle dysfunction syndrome